These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 34175786)

  • 1. Primary care physicians' preparedness to treat opioid use disorder in the United States: A cross-sectional survey.
    Foti K; Heyward J; Tajanlangit M; Meek K; Jones C; Kolodny A; Alexander GC
    Drug Alcohol Depend; 2021 Aug; 225():108811. PubMed ID: 34175786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder.
    Haffajee RL; Andraka-Christou B; Attermann J; Cupito A; Buche J; Beck AJ
    Subst Abuse Treat Prev Policy; 2020 Sep; 15(1):69. PubMed ID: 32928272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudinal barriers to buprenorphine prescription and former waiver training.
    Gannon MP; Tello M; Wakeman S; Charles JP; Lipsitz S; Samal L
    J Opioid Manag; 2024; 20(4):339-346. PubMed ID: 39321054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?
    Rhee TG; Rosenheck RA
    Addiction; 2019 Nov; 114(11):1992-1999. PubMed ID: 31307111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why aren't physicians prescribing more buprenorphine?
    Huhn AS; Dunn KE
    J Subst Abuse Treat; 2017 Jul; 78():1-7. PubMed ID: 28554597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Resident Physicians' Knowledge of and Attitudes Towards Prescribing Buprenorphine for Patients With Opioid Use Disorder.
    Shuey B; Lee D; Ugalde I; Borgan S; Bresnan C; Qureshi M; Mhaskar R; Oxner A
    J Addict Med; 2021 May-Jun 01; 15(3):219-225. PubMed ID: 33079729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine Waiver Attitudes Among Primary Care Providers.
    Lai B; Croghan I; Ebbert JO
    J Prim Care Community Health; 2022; 13():21501319221112272. PubMed ID: 35822763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing waivered and non-waivered physician barriers to treating patients with substance use disorders: a cross-sectional Kentucky pilot.
    Thompson RA; Johnson D; Kizewski AL; Baier L; Coburn K; White J; Bunn T; Fletcher EL
    J Addict Dis; 2022; 40(4):518-526. PubMed ID: 35238283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey of Barriers and Facilitators to Prescribing Buprenorphine and Clinician Perceptions on the Drug Addiction Treatment Act of 2000 Waiver.
    Lanham HJ; Papac J; Olmos DI; Heydemann EL; Simonetti N; Schmidt S; Potter JS
    JAMA Netw Open; 2022 May; 5(5):e2212419. PubMed ID: 35552721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing System and Clinician Barriers to Emergency Department-initiated Buprenorphine: An Evaluation of Post-intervention Physician Outcomes.
    Mahal JJ; Bijur P; Sloma A; Starrels J; Lu T
    West J Emerg Med; 2024 May; 25(3):303-311. PubMed ID: 38801034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescribing Practices of Nurse Practitioners and Physician Assistants Waivered to Prescribe Buprenorphine and the Barriers They Experience Prescribing Buprenorphine.
    Andrilla CHA; Jones KC; Patterson DG
    J Rural Health; 2020 Mar; 36(2):187-195. PubMed ID: 31650634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Completing X-Waiver Training and Clinical Addiction Exposure on Internal Medicine Residents Treating Patients With Opioid Use Disorder.
    Callister C; Porter S; Vatterott P; Keniston A; McBeth L; Mann S; Calcaterra SL; Limes J
    Subst Use Addctn J; 2024 Jul; 45(3):356-366. PubMed ID: 38258815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey of barriers and facilitators to the adoption of buprenorphine prescribing after implementation of a New Jersey-wide incentivized DATA-2000 waiver training program.
    Nyaku AN; Zerbo EA; Chen C; Milano N; Johnston B; Chadwick R; Marcello S; Baston K; Haroz R; Crystal S
    BMC Health Serv Res; 2024 Feb; 24(1):179. PubMed ID: 38331802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
    Jones CM; McCance-Katz EF
    Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming Barriers to Prescribing Buprenorphine for the Treatment of Opioid Use Disorder: Recommendations from Rural Physicians.
    Andrilla CHA; Moore TE; Patterson DG
    J Rural Health; 2019 Jan; 35(1):113-121. PubMed ID: 30339720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, Distribution, and Characteristics Associated With Possession of Buprenorphine Waivers Among Infectious Diseases Physicians in the United States.
    Fujita AW; Loughry N; Moore DE; Carter AE; Hussen SA; Cooper H; Colasanti JA; Sheth AN
    Clin Infect Dis; 2023 Apr; 76(7):1197-1204. PubMed ID: 36419250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Policy Change on Access to Medication for Opioid Use Disorder in Primary Care.
    Krupp J; Hung F; LaChapelle T; Yarrington ME; Link K; Choi Y; Chen H; Marais AD; Sachdeva N; Chakraborty H; McKellar MS
    South Med J; 2023 Apr; 116(4):333-340. PubMed ID: 37011580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of a Multimodal Educational Intervention for Primary Care Physicians With Prescriptions of Buprenorphine for Opioid Use Disorders.
    Clark B; Kai M; Dix R; White J; Rozenfeld Y; Levy S; Engstrom K
    JAMA Netw Open; 2019 Oct; 2(10):e1913818. PubMed ID: 31642929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in buprenorphine prescribing readiness among primary care professionals with and without X-waiver training in the US.
    Franz B; Dhanani LY; Hall OT; Brook DL; Simon JE; Miller WC
    Harm Reduct J; 2023 Dec; 20(1):180. PubMed ID: 38129903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding Opioid Use Disorder Treatment in Priority Areas: The Role of Certified Nurse-Midwives.
    Kane C; Topmiller M
    J Midwifery Womens Health; 2022 May; 67(3):314-320. PubMed ID: 35506768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.